Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron therapy on platelet counts in patients with IBD-associated anemia. METHODS: Platelet counts were analyzed before and after iron therapy from four prospective clinical trials. Further, changes in hemoglobin, transferrin saturation, ferritin, C-reactive protein, and leukocyte counts, before and after iron therapy were compared. In a subgroup the effect of erythropoietin treatment was tested. The results were confirmed in a large independent cohort (FERGIcor). RESULTS: A total of 308 patient records were available for the initial analysis. A dose-depended drop in platelet counts (mean 425 G/L to 320 G/L; p<0.001) was found regardless of the type of iron preparation (iron sulphate, iron sucrose, or ferric carboxymaltose). Concomitant erythropoietin therapy as well as parameters of inflammation (leukocyte counts, C-reactive protein) had no effect on the change in platelet counts. This effect of iron therapy on platelets was confirmed in the FERGIcor study cohort (n=448, mean platelet counts before iron therapy: 383 G/L, after: 310 G/L, p<0.001). CONCLUSION: Iron therapy normalizes elevated platelet counts in patients with IBD-associated anemia. Thus, iron deficiency is an important pathogenetic mechanism of secondary thrombocytosis in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As detailed elsewhere in this special issue, both absolute ID and inflammation can also result in thrombocytosis due to the effects of altered thrombopoietin, EPO, and IL-6 levels on megakaryopoiesis [105–107].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494 · cited 1×
“IBD-associated anemia is caused by a combination of anemia of chronic disease and iron deficiency [10].”
BackgroundGasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., Gomollon, F., Hjortswang, H., Koutroubakis, I., Kulnigg, S., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20285 · Cited by 450 · cited 1×
“Accordingly, guidelines recommend iron replacement in combination with anti-inflammatory drugs and/or erythropoietin [11,12].”
BackgroundEvstatiev, R., Marteau, P., Iqbal, T., Khalif, I. L., Stein, J., Bokemeyer, B., Chopey, I. V., Gutzwiller, F. S., Riopel, L., & Gasche, C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.005 · Cited by 367 · cited 2×
“To confirm these unexpected findings we also analyzed a recent independent cohort of patients (from FERGIcor; [16]).”
MethodResultSelf-citationKulnigg, S., Stoinov, S., Simanenkov, V., Dudar, L. V., Karnafel, W., Garcia, L. C., Sambuelli, A. M., D'Haens, G., & Gasche, C. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01744.x · Cited by 349 · cited 1×
“In the ‘‘Ferric carboxymaltose study’’ [49], 200 patients with anemia and IBD were randomized 2:1 to ferric carboxymaltose (total median amount 1400 mg iron, n = 137) or oral iron sulphate (200 mg/day, n = 63).”
BackgroundSystematic review: managing anaemia in Crohn's disease
KULNIGG, S., & GASCHE, C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03146.x · Cited by 325 · cited 1×
“About one third of patients with inflammatory bowel disease (IBD) suffer from anemia [6–9].”
BackgroundDiagnosis and management of iron deficiency anemia in patients with IBD
Stein, J., Hartmann, F., & Dignass, A. U. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.151 · Cited by 304 · cited 1×
“About one third of patients with inflammatory bowel disease (IBD) suffer from anemia [6–9].”
BackgroundPlatelets Kill Intraerythrocytic Malarial Parasites and Mediate Survival to Infection
McMorran, B. J., Marshall, V. M., de Graaf, C., Drysdale, K. E., Shabbar, M., Smyth, G. K., Corbin, J. E., Alexander, W. S., & Foote, S. J. (2009) · Science · doi:10.1126/science.1166296 · Cited by 291
Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications
Danese, S., Motte, C. D. L., & Fiocchi, C. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04129.x · Cited by 253 · cited 1×
“Some authors propose that activated platelets are involved in the pathogenesis of IBD [14,15].”
BackgroundSIMANEK, R., VORMITTAG, R., AY, C., ALGUEL, G., DUNKLER, D., SCHWARZINGER, I., STEGER, G., JAEGER, U., ZIELINSKI, C., & PABINGER, I. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03680.x · Cited by 249 · cited 1×
“In cancer patients thrombocytosis is an independent risk factor for thromboembolic events [45].”
BackgroundAnemia and inflammatory bowel diseases
Gomollón, F., & Gisbert, J. P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4659 · Cited by 194 · cited 1×
“About one third of patients with inflammatory bowel disease (IBD) suffer from anemia [6–9].”
Background
Cited by
‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients
Muñoz, M., Gómez-Ramírez, S., Kozek-Langeneker, S., Shander, A., Richards, T., Pavía, J., Kehlet, H., Acheson, A. G., Evans, C., Raobaikady, R., et al. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev165 · Cited by 238
“enhances the response to rHuEPO allowing dose reduction and reduction of platelet counts diminishing thrombotic risk.(66) 20 | Muñoz et al.”
BackgroundWallaert, J. B., De Martino, R. R., Marsicovetere, P. S., Goodney, P. P., Finlayson, S. R. G., Murray, J. J., & Holubar, S. D. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e3182698f60 · Cited by 149
“A recent study demonstrated that iron therapy in patients with IBD-associated anemia normalizes thrombocytosis, thus decreasing the risk of thrombosis.(15) In our VTE subgroup, 62% of patients had a preoperative hematocrit <37%, whereas only 2% had recently received a transfusion.”
BackgroundNairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
Evstatiev, R., Bukaty, A., Jimenez, K., Kulnigg‐Dabsch, S., Surman, L., Schmid, W., Eferl, R., Lippert, K., Scheiber‐Mojdehkar, B., Michael Kvasnicka, H., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23682 · Cited by 124
“In addition, ID-induced thrombocytosis resolves upon iron replacement even in patients receiving erythropoiesis stimulating agents [3,4,30].”
BackgroundResultSelf-citationFerric Carboxymaltose: A Review of Its Use in Iron Deficiency
Keating, G. M. (2014) · Drugs · doi:10.1007/s40265-014-0332-3 · Cited by 138
“2) suggests that iron deficiency may be an important mechanism underlying secondary thrombocytosis [17, 18].”
BackgroundManagement of Iron Deficiency Anemia.
(2015) · PubMed Central · Cited by 136
Self-citationIntestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD
Welden, S. V., Selfridge, A. C., & Hindryckx, P. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.101 · Cited by 132
Multipotent role of platelets in inflammatory bowel diseases: A clinical approach
Voudoukis, E., Κarmiris, K., & Κoutroubakis, I. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3180 · Cited by 118
Bisbe, E., Moltó, L., Arroyo, R., Muniesa, J. M., & Tejero, M. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu092 · Cited by 105
Murawska, N., Fabisiak, A., & Fichna, J. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000648 · Cited by 105
“Detecting the iron deficiency before the anemia develops could shorten the therapy, lower the costs, and prevent the possible thrombotic events in these patients.(134) Not to mention the convenience of patients, which would be brought by such approach.”
BackgroundSevere anemia from heavy menstrual bleeding requires heightened attention
Nelson, A. L., & Ritchie, J. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.04.023 · Cited by 97
Iron therapy in anaemic adults without chronic kidney disease
Gurusamy, K. S., Nagendran, M., Broadhurst, J., Anker, S. D., & Richards, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010640.pub2 · Cited by 79
Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats
Jimenez, K., Leitner, F., Leitner, A., Scharbert, G., Schwabl, P., Kramer, A.-M., Krnjic, A., Friske, J., Helbich, T. H., Evstatiev, R., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.245092 · Cited by 77
Self-citationKulnigg‐Dabsch, S., Schmid, W., Howaldt, S. M., Stein, J. M., Mickisch, O., Waldhoer, T., Evstatiev, R., Kamali, H., Volf, I., & Gasché, C. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f4db · Cited by 73
“This study evaluated the effect of FCM on secondary thrombocytosis and thrombocyte activity in IBD.”
BackgroundResultInfluentialSelf-citationLaass, M. W., Straub, S., Chainey, S., Virgin, G., & Cushway, T. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-184 · Cited by 71
“However, similar reductions have been seen in other studies using FCM, where a decrease of platelets was observed independent of inflammation markers such as C-reactive protein [19].”
ResultPlatelet Abnormalities during Colonic Inflammation
Yan, S. L.-S., Russell, J., Harris, N. R., Senchenkova, E. Y., Yıldırım, A., & Granger, D. N. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f3df · Cited by 63
Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease
Voudoukis, E., Κarmiris, K., Oustamanolakis, P., Theodoropoulou, A., Sfiridaki, A., Paspatis, G. A., & Κoutroubakis, I. E. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328363e354 · Cited by 57
Chi, G., Gibson, C. M., Hernandez, A. F., Hull, R. D., Kazmi, S. H. A., Younes, A., Walia, S. S., Pitliya, A., Singh, A., Kahe, F., et al. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.03.031 · Cited by 56
Quintana‐Díaz, M., Fabra, S., Gómez‐Ramírez, S., Martínez-Virto, A. M., García‐Erce, J. A., & Múñoz, M. (2016) · PubMed · doi:10.2450/2015.0176-15 · Cited by 49
“Patient blood management” en cirugía ortopédica
Canillas, F., Gómez‐Ramírez, S., García‐Erce, J. A., Pavía, J., Gómez‐Luque, A., & Múñoz, M. (2015) · Revista Española de Cirugía Ortopédica y Traumatología · doi:10.1016/j.recot.2014.11.005 · Cited by 43
Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide
Gomollón, F., & Gisbert, J. P. (2013) · Drugs · doi:10.1007/s40265-013-0131-2 · Cited by 41
“For instance, a role of iron deficiency in thrombocytosis and platelet activation has been suggested by experimental and clinical data [45, 46], and a recent trial has demonstrated that intravenous iron can normalize platelet counts and decrease platelet activation in IBD patients [47].”
BackgroundIncreased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation
Jimenez, K., Khare, V., Evstatiev, R., Kulnigg‐Dabsch, S., Jambrich, M., Strobl, H., & Gasché, C. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12884 · Cited by 40
Self-citationShort‐term perioperative iron in major orthopedic surgery: state of the art
Gómez‐Ramírez, S., Maldonado‐Ruiz, M. Á., Campos‐Garrigues, A., Herrera, A., & Múñoz, M. (2018) · Vox Sanguinis · doi:10.1111/vox.12718 · Cited by 37
Peri‐operative correction of non‐anaemic iron deficiency. A reply
Muñoz, M. J., & deficiency, T. P. F. T. I. C. S. O. P. M. O. A. I. (2017) · Anaesthesia · doi:10.1111/anae.13947 · Cited by 36
Iron deficiency anemia and thrombosis risk in children—revisiting an old hypothesis
Kalff, H., Cario, H., & Holzhauer, S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.926925 · Cited by 35
Potaczek, D. P., Jankowska, E. A., Wypasek, E., & Undas, A. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3311 · Cited by 34
Nakarai, A., Kato, J., Hiraoka, S., Takashima, S., Inokuchi, T., Takahara, M., Sugihara, Y., Harada, K., & Okada, H. (2018) · Gut and Liver · doi:10.5009/gnl17236 · Cited by 31
“Previous studies indicated that iron deficiency increases and iron supplementation decreases platelet count in IBD patients with anemia.(25,26) Although our analysis did not include parameters associated with iron and ferritin levels, our patients did not show anemia due to MH and hemoglobin levels did not differ sign…”
BackgroundEssential Thrombocythemia in Children and Adolescents
Putti, M. C., Bertozzi, I., & Randi, M. L. (2021) · Cancers · doi:10.3390/cancers13236147 · Cited by 29
“Studies on megakaryocytes demonstrated that iron is essential for their proliferation as for other cells [38], and iron replacement resolves thrombocytosis [39].”
BackgroundEisenmangel, Thrombozytose und Thromboembolie
Evstatiev, R. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0514-6 · Cited by 26
“zahl auch bei Patienten, die EPO erhalten [21, 22, 41].”
BackgroundSelf-citationPlatelet reactivity and platelet count in women with iron deficiency treated with intravenous iron
Elstrott, B. K., Lakshmanan, H. H. S., Melrose, A. R., Jordan, K. R., Martens, K. L., Yang, C., Peterson, D. F., McMurry, H. S., Lavasseur, C. M., Lo, J. O.-T., et al. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12692 · Cited by 24
Effect of iron supplementation on platelet count in adult patients with iron deficiency anemia
Li, X., Li, N., Zhao, G., & Wang, X. (2022) · Platelets · doi:10.1080/09537104.2022.2091772 · Cited by 23
“Iron therapy also has been found to reduce platelet count in reactive thrombocytosis in various groups of patients such as inflammatory bowel disease [20,21], chronic kidney disease [22,23], and cancer [24].”
BackgroundToblli, J. E., & Gennaro, F. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125528 · Cited by 20
“FCM reduced secondary thrombocytosis, platelet aggregation and P-selectin expression [38].”
Background“Patient Blood Management” in orthopedic surgery
Canillas, F., Gómez‐Ramírez, S., García‐Erce, J. A., Pavía, J., Gómez‐Luque, A., & Múñoz, M. (2015) · Revista Española de Cirugía Ortopédica y Traumatología · doi:10.1016/j.recote.2015.03.009 · Cited by 13
Anaemia in inflammatory bowel disease
Dibb, M. J., & Subramanian, S. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100388 · Cited by 11
Intravenous iron and safety: is the end of the debate on the horizon?
Múñoz, M., Gómez‐Ramírez, S., Liumbruno, G. M., & Grazzini, G. (2014) · PubMed · doi:10.2450/2014.0144-14 · Cited by 11
Shim, H., Lee, Y. J., Kim, J. H., Lim, M. C., Lee, D.-E., Park, S., & Kong, S. (2024) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2024.35.e38 · Cited by 9
Platelet levels before and after iron replacement therapy in patients with iron deficiency anemia
Talamo, G., Oyeleye, O. A., Paudel, A., Tayyab, H., Khan, M., Meseeha, M., & Bhatta, G. (2025) · Hematology · doi:10.1080/16078454.2025.2458358 · Cited by 6
“Previous studies have shown that iron replacement therapy can lower platelet count and correct reactive thrombocytosis in different contexts of IDA, like inflammatory bowel disease [9], chronic kidney disease (CKD) [10], and pre-menopausal women [11].”
Liao, R., Zhou, X., Ma, D., Tang, J., & Zhong, H. (2022) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2021.09.004 · Cited by 6
Radziejewska, A., Suliburska, J., Kolodziejski, P. A., Żuk, E., & Chmurzyńska, A. (2021) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.0921 · Cited by 5
“This is inconsistent with the fact that Plt concentrations reflect the iron level in the body (Kulnigg-Dabsch et al., 2012).”
BackgroundUlcerative colitis and thrombocytosis: Case report and literature review
Zhou, Y., Zhu, F., Jing, D., Wang, Q., & Zhou, G. (2023) · Medicine · doi:10.1097/md.0000000000033784 · Cited by 4
“[17] Iron deficiency may be an important mechanism of RT, and iron supplementation therapy in patients with IBD anemia normalizes PLT count and reduces PLT activity.[32,33] In our case, giving the patient iron supplementation was also beneficial in the treatment of RT.”
BackgroundA Paradigm Shift: Perioperative Iron and Erythropoietin Therapy for Patient Blood Management
Lee, H., & Yuh, Y. J. (2018) · Hanyang Medical Reviews · doi:10.7599/hmr.2018.38.1.16 · Cited by 4
“Iron supplementation with ESAs can be helpful in treating anemic patients with CKD or inflammatory bowel disease [19,33].”
BackgroundShentova-Eneva, R., & Velikova, T. V. (2020) · Gastroenterology Insights · doi:10.3390/gastroent11020009 · Cited by 4
“[35], anemia in IBD results in increased erythropoietin production, which is a structural homolog of thrombopoietin.”
BackgroundHagiwara, K., Watanabe, Y., Suzuki, T., Okamura, Y., & Yamashita, H. (2023) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12709 · Cited by 4
“27 13 Anemia is associated with underlying conditions associated with VTE, such as malnutrition, 28 chronic inflammation, 29 and malignant disease.”
BackgroundThrombocytosis in 158 cats (2011–2018)
Howard, L. A., Woolcock, A. D., Christian, J. A., & Moore, G. E. (2023) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x231185680 · Cited by 4
Ayan, N. N., Savas, Z., Bireroğlu, N., Keles, A., Aksoy, N., & Serin, N. O. (2015) · Journal of Academic Research in Medicine · doi:10.5152/jarem.2015.712 · Cited by 3
“A number of changes in platelet count (PLT) have been reported in IDA (2).”
BackgroundInfluentialFerric carboxymaltose: a guide to its use in iron deficiency
Keating, G. M. (2015) · Drugs & Therapy Perspectives · doi:10.1007/s40267-015-0203-3 · Cited by 2
“… in inflammatory bowel disease … Intravenous ferric carboxymaltose was more effective than intravenous iron sucrose [18] and noninferior to oral ferrous sulfate [19] in patients with IBD and iron-deficiency anaemia (n = 485 [18] and n = 200 [19]).”
BackgroundInfluentialAzeem, M., Sharif, M. K., Shah, F.-U.-H., Ali, M., Nazir, M. A., Rizwan, M., Wadood, S. A., & Ejaz, R. (2021) · Italian Journal of Food Science · doi:10.15586/ijfs.v33i1.1804 · Cited by 2
“Current results are consistent with the finding of Kulnigg-Dabsch et al. (2012).”
ResultNelson, R. E., Hoop, R., Korner, E. J., DuVall, S. L., Hayden, C. L., Knippenberg, K., Morgan, T. R. M., Pandya, P., Han, J., & LaFleur, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014531724 · Cited by 2
When Iron Bites Back: Severe Thrombocytopenia After Intravenous Iron Sucrose Therapy (Venofer)
Lak, M. A., Paleri, A., Satheesh, M., Abdelhamid, D., Prisco, M., Shoaib, U., & Ahmad, A. (2026) · Cureus · doi:10.7759/cureus.109185 · Cited by 1
“Similar findings were reported in the FERGIcor cohort (n = 448), where platelet counts decreased from 383 G/L to 310 G/L (p 0.001) [9].”
InfluentialKadiri, M. A., Ojezele, M. O., Igben, O., Efeurhobo, O. D., & Imolede, I. O. (2025) · Emerging Frontiers in Translational Biomedicine and Health Sciences · doi:10.66779/kyxh7d04 · Cited by 1
Nicola, H., Ho, K. M., & Cordingley, F. T. (2016) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1604400614 · Cited by 1
Richmond, S. (2016) · ERA · Cited by 1
Iron in the biology and treatment of gastrointestinal cancer
Ng, O. (2019) · Nottingham ePrints (University of Nottingham)
Effect of parenteral iron treatment on platelet counts in women who do not have concomitant diseases
ALANLI, R., & KÜÇÜKAY, M. B. (2022) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_7_22
Humoral immunity and thrombosis in COVID-19
Lasagni, G., Borghi, M. O., Cugno, M., & Meroni, P. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00037-2
Goldfarb, Y. S., Badalyan, A. V., Макаров, М. С., Боровкова, Н. В., Potskhveriya, М. М., Биткова, Е. Е., & Никонорович, Е. А. (2025) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2025-17-3-291-308
Adeli Sardoo, H. (2021) · Research Information System of Ardabil University of Medical Sciences (Ardabil University of Medical Sciences)
Utilitat del ferro endovenós per al tractament de l'anèmia periquirúrgica en cirurgia ortopèdica
Vives, E. B., & de Cirurgia, U. A. D. B. D. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Metadata
- Authors
- Kulnigg-Dabsch, S., Evstatiev, R., Dejaco, C., & Gasche, C.
- Affiliations
- Medical University of Vienna (AT)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-10
- Volume
- 7
- Issue
- 4
- Pages
- e34520
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3323537
- OpenAlex
- W2100551670
- Cited by
- 55
- References
- 52
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 2 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 4 · 2012: 1
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fresenius Medical Care North America
- Austrian Science Fund (P 21200)
- Vifor Pharma
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- inflammatory bowel disease, iron deficiency, secondary thrombocytosis, platelet count, iron therapy, iron supplementation, erythropoietin, anemia of chronic disease, iron sucrose, ferric carboxymaltose, iron sulfate, transferrin saturation, ferritin, C-reactive protein
- MeSH terms
- Iron Deficiencies, Blood Platelets, C-Reactive Protein, Erythropoietin, Ferritins, Hemoglobins, Humans, Iron, Leukocyte Count, Platelet Count, Prospective Studies, Thrombocytosis, Transferrin, Inflammatory Bowel Diseases, Cohort Studies, Anemia, Iron-Deficiency, Iron Compounds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.